MedTech News
New device helps paraplegics regain partial use of hands
More than 40 people suffering from paralysis from the neck down regained partial control of their arms and hands thanks to a relatively simple to use device, a large study said Monday.
Shoulder Innovations launches new humeral stem
Shoulder Innovations today announced it launched its InSet 95 Humeral Stem.
FastWave Medical picks up another IVL patent
FastWave Medical announced that the United States Patent and Trademark Office (USPTO) issued it another intravascular lithotripsy (IVL) utility patent.
InventHelp Inventor Develops Improved Shaver for Surgical Incision Sites (DAL-429)
The invention provides an effective way to shave and remove the hair from a surgical incision site
FDA clears next-gen Medtronic PillCam solution suite
Medtronic (NYSE: MDT)+
officials say the company received FDA clearance for the next-generation PillCam Genius SB capsule endoscopy kit.
Miniaturized optical coherence tomography imaging probe takes pictures inside cerebral arteries
A large international team of micro-engineers, medical technologists, and neurosurgeons, has designed, built and tested a new type of probe that can be used to take pictures from inside arteries in the brain.
FX Shoulder Solutions, Inc. Receives FDA 510k Clearance for Full-Wedge Augmented Glenoid Baseplates
ADDISON, Texas , May 16, 2024 /PRNewswire/ — FX received 510k clearance for its full-wedge augmented glenoid baseplates. The newly cleared baseplates bring 6 new options to the previously cleared portfolio. There are now a combined total of 18 glenoid baseplate options to the market to address a variety of surgeon needs. Augmented glenoid baseplate options have continued to become a growing solution for surgeons to address bone loss, defects, or complicated morphologies of the glenoid.
FDA Grants EUA to Wondfo’s WELLlife™ COVID-19/Influenza A&B Test Supported by DCN Dx Clinical Research
CARLSBAD, Calif., May 15, 2024 /PRNewswire/ — DCN Dx, a leading contract research organization for in vitro diagnostics, today acknowledges the FDA’s Emergency Use Authorization (EUA) of the WELLlife™ COVID-19/Influenza A&B Test, developed by Wondfo USA. This important authorization will enable healthcare professionals to differentiate rapidly between COVID-19 and influenza infections, enhancing patient care at the point-of-care.